INS and polycystic ovary syndrome: Metformin (MET), the most extensively used insulin-lowering drug in PCOS (21), reduces hepatic glucose production, inhibits gluconeogenesis and lipogenesis, and enhances insulin sensitivity in peripheral tissues (22).